Optiscan Imaging Stock

Optiscan Imaging ROA

The Return on Assets (ROA) of Optiscan Imaging (OIL.AX) as of Sep 9, 2026 is -59.80 %. In the previous year, Return on Assets (ROA) was -38.77 % — a change of 54.22% (lower).

ROA

-59.80 %

YoY

54.22%

Last updated:

In 2026, Optiscan Imaging's return on assets (ROA) was -59.80 %, a 54.22% increase from the -38.77 % ROA in the previous year.

The Optiscan Imaging ROA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

ROA
Date
ROA
Jan 1, 2018
-49.28 AUD
Jan 1, 2019
-64.32 AUD
Jan 1, 2020
-51.25 AUD
Jan 1, 2021
-18.18 AUD
Jan 1, 2022
-53.02 AUD
Jan 1, 2023
-93.14 AUD
Jan 1, 2024
-38.77 AUD
Jan 1, 2025
-59.80 AUD
The Optiscan Imaging ROA history
YEARROAYoY
-59.80 %+54.22%
-38.77 %-58.37%
-93.14 %+75.68%
-53.02 %+191.59%
-18.18 %-64.52%
-51.25 %-20.32%
-64.32 %+30.52%
-49.28 %-55.35%
-110.36 %+50.28%
-73.43 %-46.42%
-137.05 %-20.86%
-173.17 %—
Access this data via the Eulerpool API
Get Free API Key

Optiscan Imaging Stock analysis

What does Optiscan Imaging do? Optiscan Imaging Ltd is an Australian company specializing in the development and commercialization of advanced imaging technologies. The company was founded in 1994 and is headquartered in Notting Hill, a suburb of Melbourne. Optiscan was originally established as a spin-off company from Monash University to enable the commercial application of a groundbreaking technology called confocal microscopy. However, over the years, the company has expanded into other imaging technologies and now offers a wide range of products and services. Optiscan's business model involves developing and bringing to market innovative technologies that can be used in biomedical research and clinical diagnostics. The company works closely with research institutions and companies in various industries to develop customized imaging solutions. Optiscan offers a wide range of products, including confocal microscopes, multiphotonic microscopes, real-time imaging systems, and Raman spectrometers. These products are used in various application areas such as cancer research, neurobiology, cell biology, and materials science. Another important area for Optiscan is veterinary imaging. The company has developed a product line for veterinary medicine that is used by veterinarians and researchers around the world. Optiscan's imaging systems enable veterinarians to obtain precise and detailed images of animals to enable better diagnosis and treatment. Optiscan also operates a service department that offers customized imaging solutions to customers. The company provides services such as image processing, data analysis, and prototype development. Overall, Optiscan has become one of the leading providers of imaging technologies in Australia and globally over the past decades. The company has a long history of collaboration with leading research institutions and companies worldwide and remains committed to developing innovative solutions for the challenges of biomedicine and imaging. Optiscan Imaging is one of the most popular companies on Eulerpool.

ROA Details

Understanding Optiscan Imaging's Return on Assets (ROA)

Optiscan Imaging's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing Optiscan Imaging's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider Optiscan Imaging's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in Optiscan Imaging’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about Optiscan Imaging stock

Return on Assets (ROA) of Optiscan Imaging is -59.80 % in 2026.

Return on Assets (ROA) of Optiscan Imaging changed from -38.77 % to -59.80 %, representing a 54.22% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Return on Assets (ROA) Optiscan Imaging since 2006 – with annual values, charts, and detailed analysis.

Return on Assets, also known as ROA, is a financial metric used to measure a company's profitability. It is used to determine how effectively a company uses its assets to generate profits. It is also referred to as the ratio of net income to total assets. ROA is an important indicator of a company's overall financial performance as it measures the company's ability to generate more profit from the assets it employs.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Assets (ROA)'s Optiscan Imaging with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Assets (ROA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Assets (ROA).

Access this data via the Eulerpool API
Get Free API Key

Profitability — Optiscan Imaging

ROEROAROCEROICAsset TurnoverInventory TurnoverReceivables TurnoverDays Sales OutstandingDays Inventory OutstandingDays Payable OutstandingCash Conversion CycleCROICGross Profit/AssetsFixed Asset TurnoverEquity TurnoverWorking Capital TurnoverPayables TurnoverCapital IntensityReceivables/RevenueInventory/RevenueEBIT/Assets

All Key Metrics — Optiscan Imaging